Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.36 | €55.00 | 5.042% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €216.90 | €247.61 | 14.157% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €128.00 | €150.00 | 17.188% |
| Davita Inc. | 2 | 0 | 0 | 0 | €127.10 | €124.89 | -1.740% |
| Integer Hldg | 1 | 0 | 0 | 0 | €102.00 | - | - |
| Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 0 | 0 | €69.00 | €73.92 | 7.130% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €18.40 | €45.10 | 145.082% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €340.60 | €369.72 | 8.551% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €67.36 | €85.68 | 27.204% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €14.45 | - | - |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.80 | €65.00 | -2.695% |
| Sartorius AG VZO | 4 | 0 | 0 | 0 | €282.60 | - | - |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €12.90 | €25.20 | 95.371% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €93.00 | €124.85 | 34.245% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.99 | - | - |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €74.00 | - | - |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.00 | €79.00 | 8.219% |
| Amedisys Inc. | 14 | 0 | 1 | 0 | €84.00 | €92.26 | 9.833% |
| Korian S.A. | 1 | 0 | 1 | 0 | €2.58 | - | - |
| Uniqure B.V. | 1 | 0 | 1 | 0 | €4.39 | - | - |
| Alkermes plc | 12 | 2 | 1 | 0 | €22.00 | €34.08 | 54.912% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €86.00 | €97.90 | 13.840% |